drugset / Trial / NCT07272278

Prospective Clinical Study on the Clinical Efficacy and Prognostic Outcome of ICS/LABA Combined With Liqin Zhike Formula in the Treatment of Cough Variant Asthma

NCT07272278 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

To investigate the impact of the combination of ICS/LABA and Liqin Zhike Formula on the clinical efficacy and prognostic outcomes of cough variant asthma.

Timeline

Start
2025-12-01
Primary completion
2026-12-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Liqin Zhike Formula Traditional medicine (herbal / TCM) — —

Indications